The Alzheimer’s disease drug development landscape
Speaker
Dr. Jort Vijverberg
Neurologist
Dr. Jort Vijverberg is a neurologist at the Brain Research Center and a senior researcher at Alzheimercentrum Amsterdam. He has been the principal investigator on many Alzheimer’s clinical trials and consults with the pharmaceutical industry.
Hosted by: Julius Clinical.
Speakers:
- Pieter van Bokhoven | CSO| IAO Amsterdam Neuroscience AUMC
- Jort Vijverberg | Neurologist | Amsterdam Neuroscience AUMC
Topics that are discussed during this webinar:
- All major trends in Alzheimer drug development
- Implications for drug development strategies
Related webinars
Webinar – Improving ALS Trial Delivery Through Insights from Patient and Industry Experience
On January 19, at 16.30 CET, we will present the webinar: Improving ALS Trial Delivery Through Insights from Patient and Industry ExperienceWhat You’ll LearnPatient- and Industry-Informed Insights Top patient-experience pitfalls obs...
Webinar – Boosting patient enrolment and retention in clinical trials: Expert Insights & Tips
On June 30, at 16.00 CEST, we will present the webinar: Boosting patient enrolment and retention in clinical trials: Expert Insights & TipsJoin us for an interactive discussion with experts who will draw upon recent cardiology and neurolog...
Webinar – The role of EEG in dementia trials
On May 6th, 2025, we will organised the webinar: The role of EEG in dementia trials During this webinar, our speakers Pieter van Mierlo, Dr. Willem de Haan and host Lieza Exalto will explore the following topics:Practical aspects and resti...
